Mark Connors
19Patents
5h-index
49Co-inventors
66Inventor score
Filing activity: Oct 21, 1994 → Jun 30, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5922326A | Attenuated respiratory syncytial virus vaccine compositions | Chemistry; Metallurgy | 55 | Expired |
| US8637036B2 | Neutralizing antibodies to HIV-1 and their use | Chemistry; Metallurgy | 14 | Active |
| US5882651A | Attenuated respiratory syncytial virus vaccine compositions | Chemistry; Metallurgy | 8 | Expired |
| US9695230B2 | Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein | Chemistry; Metallurgy | 7 | Active |
| US10035844B2 | Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein | Chemistry; Metallurgy | 6 | Active |
| US9175070B2 | Neutralizing antibodies to HIV-1 and their use | Chemistry; Metallurgy | 3 | Active |
| US9475862B2 | Neutralizing GP41 antibodies and their use | Physics | 2 | Active |
| US9738703B2 | Neutralizing antibodies to HIV-1 and their use | Chemistry; Metallurgy | 2 | Active |
| US10035845B2 | Neutralizing antibodies to HIV-1 and their use | Chemistry; Metallurgy | 2 | Active |
| US10562960B2 | Neutralizing antibodies to gp120 and their use | Physics | 1 | Active |
| US6284254A | Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mutants | Chemistry; Metallurgy | 1 | Expired |
| US11236152B2 | Neutralizing antibodies to HIV-1 GP41 and their use | Physics | 0 | Active |
| US10047148B2 | Neutralizing GP41 antibodies and their use | Physics | 0 | Active |
| US10815295B2 | Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein | Chemistry; Metallurgy | 0 | Active |
| US10047147B2 | Neutralizing GP41 antibodies and their use | Physics | 0 | Active |
| US12043660B2 | 10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use | Physics | 0 | Active |
| US12202886B2 | Neutralizing antibodies to GP120 and their use | Physics | 0 | Active |
| US12325734B2 | Human immunodeficiency virus-specific T cell receptors | Chemistry; Metallurgy | 0 | Active |
| US9783595B2 | Neutralizing GP41 antibodies and their use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.